EE04431B1 - Bensamidiini derivaadid ja nende kasutamine LTB-4antagonistliku mõjuga ravimitena - Google Patents
Bensamidiini derivaadid ja nende kasutamine LTB-4antagonistliku mõjuga ravimitenaInfo
- Publication number
- EE04431B1 EE04431B1 EEP199900086A EE9900086A EE04431B1 EE 04431 B1 EE04431 B1 EE 04431B1 EE P199900086 A EEP199900086 A EE P199900086A EE 9900086 A EE9900086 A EE 9900086A EE 04431 B1 EE04431 B1 EE 04431B1
- Authority
- EE
- Estonia
- Prior art keywords
- ltb
- antagonist drugs
- benzamidine derivatives
- benzamidine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/62—Compounds containing any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylcarbamates
- C07C271/64—Y being a hydrogen or a carbon atom, e.g. benzoylcarbamates
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19636689A DE19636689A1 (de) | 1996-09-10 | 1996-09-10 | Neue Benzamidinderivate |
| PCT/EP1997/004921 WO1998011062A1 (fr) | 1996-09-10 | 1997-09-09 | Derives de benzamidine et leur utilisation comme medicaments ayant un effet antagoniste vis-a-vis de ltb4 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EE9900086A EE9900086A (et) | 1999-10-15 |
| EE04431B1 true EE04431B1 (et) | 2005-02-15 |
Family
ID=7805125
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP199900086A EE04431B1 (et) | 1996-09-10 | 1997-09-09 | Bensamidiini derivaadid ja nende kasutamine LTB-4antagonistliku mõjuga ravimitena |
Country Status (31)
| Country | Link |
|---|---|
| US (2) | US6197824B1 (fr) |
| EP (2) | EP0929516B1 (fr) |
| JP (2) | JP4150427B2 (fr) |
| KR (1) | KR20000036005A (fr) |
| CN (1) | CN1104412C (fr) |
| AR (1) | AR009741A1 (fr) |
| AT (2) | ATE224363T1 (fr) |
| AU (1) | AU727900B2 (fr) |
| BG (1) | BG63938B1 (fr) |
| BR (1) | BR9712816A (fr) |
| CA (1) | CA2262566C (fr) |
| CO (1) | CO4900032A1 (fr) |
| CZ (1) | CZ297252B6 (fr) |
| DE (3) | DE19636689A1 (fr) |
| DK (1) | DK0929516T3 (fr) |
| EA (1) | EA003245B1 (fr) |
| EE (1) | EE04431B1 (fr) |
| ES (1) | ES2184131T3 (fr) |
| HK (1) | HK1020564A1 (fr) |
| HU (1) | HUP9904367A3 (fr) |
| IL (1) | IL128144A (fr) |
| NO (1) | NO312239B1 (fr) |
| NZ (1) | NZ334895A (fr) |
| PL (1) | PL188012B1 (fr) |
| PT (1) | PT929516E (fr) |
| SK (1) | SK282432B6 (fr) |
| TR (1) | TR199900501T2 (fr) |
| TW (1) | TW378200B (fr) |
| UA (1) | UA60315C2 (fr) |
| WO (1) | WO1998011062A1 (fr) |
| ZA (1) | ZA978045B (fr) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2198871C1 (ru) | 1998-12-14 | 2003-02-20 | Ф.Хоффманн-Ля Рош Аг | Фенилглициновые производные |
| US6291531B1 (en) * | 1999-10-07 | 2001-09-18 | Boehringer Ingelheim Pharma Kg | LTB4 antagonist, processes for the preparation thereof and its use as a pharmaceutical composition |
| DE19948428A1 (de) * | 1999-10-07 | 2001-04-12 | Boehringer Ingelheim Pharma | Neuer LTB¶4¶-Antagonist, Verfahren zu dessen Herstellung und dessen Verwendung als Arzneimittel |
| US6528491B2 (en) | 2000-10-24 | 2003-03-04 | Boehringer Ingelheim Pharma Kg | Pyranoside derivatives |
| DE10052658A1 (de) * | 2000-10-24 | 2002-05-02 | Boehringer Ingelheim Pharma | Neue Pyranosidderivate |
| US6489359B2 (en) | 2000-10-24 | 2002-12-03 | Boehringer Ingelheim Pharma Kg | Sulphoxybenzamides |
| DE10052333A1 (de) * | 2000-10-24 | 2002-05-02 | Boehringer Ingelheim Pharma | Neue Sulfooxybenzamide |
| US6608054B2 (en) * | 2001-03-20 | 2003-08-19 | Boehringer Ingelheim Pharma Kg | Pharmaceutical compositions based on anticholinergics and endothelin antagonists |
| US7776315B2 (en) * | 2000-10-31 | 2010-08-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions based on anticholinergics and additional active ingredients |
| AU4239302A (en) * | 2001-06-28 | 2003-01-02 | Pfizer Products Inc. | Benzoic acid substituted benzopyrans for the treatment of atherosclerosis |
| US20030119901A1 (en) * | 2001-07-14 | 2003-06-26 | Boehringer Ingelheim Pharma Kg | Pharmaceutical formulation containing an LTB4 antagonist |
| HUP0401371A3 (en) * | 2001-07-14 | 2010-01-28 | Boehringer Ingelheim Pharma | Pharmaceutical formulation containing an ltb4 antagonist and process for its preparation |
| IL160208A0 (en) * | 2001-08-31 | 2004-07-25 | Neurochem Int Ltd | Amidine derivatives for treating amyloidosis |
| US6921752B2 (en) * | 2002-03-26 | 2005-07-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Use of LTB4 antagonists in veterinary medicine |
| DE10213350A1 (de) * | 2002-03-26 | 2003-10-16 | Boehringer Ingelheim Pharma | Verwendung von LTB¶4¶Antagonisten in der Tiermedizin |
| RS20050390A (en) * | 2002-11-26 | 2008-04-04 | Boehringer Ingelheim Pharma Gmbh. & Co.Kg., | Pharmaceutical composition comprising a ltb4 antagonist and a cox-2 inhibitor or a combined cox 1/2 inhibitor |
| US7262223B2 (en) * | 2004-01-23 | 2007-08-28 | Neurochem (International) Limited | Amidine derivatives for treating amyloidosis |
| KR100682199B1 (ko) * | 2004-07-05 | 2007-02-12 | 동화약품공업주식회사 | 알러지성 염증 질환의 예방 및 치료용 조성물 |
| KR20060017929A (ko) * | 2004-08-04 | 2006-02-28 | 동화약품공업주식회사 | 티아졸 유도체가 치환된 신규한 벤즈아미딘 유도체, 그의제조방법 및 이를 유효성분으로 하는 약학 조성물 |
| US8679288B2 (en) * | 2008-06-09 | 2014-03-25 | Lam Research Corporation | Showerhead electrode assemblies for plasma processing apparatuses |
| CN106831611B (zh) * | 2017-01-23 | 2019-06-21 | 北京化工大学 | 一种偕胺肟类化合物及其在制备抑制癌细胞增殖药的应用 |
| AU2018266393A1 (en) | 2017-05-12 | 2019-12-19 | Riken | Class A GPCR-binding compound modifier |
| AU2019350072A1 (en) * | 2018-09-24 | 2021-04-29 | The University Of British Columbia | Modulation of Granzyme K activity in the treatment of skin conditions |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4102024A1 (de) * | 1991-01-24 | 1992-07-30 | Thomae Gmbh Dr K | Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| US5246965A (en) | 1991-06-11 | 1993-09-21 | Ciba-Geigy | Arylethers, their manufacture and methods of treatment |
| EP0518818A3 (en) * | 1991-06-11 | 1993-04-28 | Ciba-Geigy Ag | Arylethers, their manufacture and use as medicament |
| DK0902013T3 (da) * | 1992-02-05 | 2002-03-25 | Boehringer Ingelheim Pharma | Hidtil ukendte amidinderivater, deres fremstilling og anvendelse som lægemidler med LTB4-antagonistisk virkning |
| DE4219158A1 (de) * | 1992-06-11 | 1993-12-16 | Thomae Gmbh Dr K | Biphenylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| DE4424713A1 (de) * | 1994-07-13 | 1996-01-18 | Boehringer Ingelheim Kg | Substituierte Benzamidine, ihre Herstellung und Verwendung als Arnzneistoffe |
| DE4424714A1 (de) * | 1994-07-13 | 1996-01-18 | Boehringer Ingelheim Kg | Neue chemische Verbindung, ihre Herstellung und ihre Verwendung als Arnzneistoff |
| DE19546452A1 (de) * | 1995-12-13 | 1997-06-19 | Boehringer Ingelheim Kg | Neue Phenylamidinderivate, Verfahren zu ihrer Herstelung und ihre Verwendung als Arzneimittel |
-
1996
- 1996-09-10 DE DE19636689A patent/DE19636689A1/de not_active Withdrawn
-
1997
- 1997-09-08 ZA ZA9708045A patent/ZA978045B/xx unknown
- 1997-09-09 UA UA99042008A patent/UA60315C2/uk unknown
- 1997-09-09 EP EP97942007A patent/EP0929516B1/fr not_active Expired - Lifetime
- 1997-09-09 CO CO97052335A patent/CO4900032A1/es unknown
- 1997-09-09 EE EEP199900086A patent/EE04431B1/xx not_active IP Right Cessation
- 1997-09-09 IL IL12814497A patent/IL128144A/en not_active IP Right Cessation
- 1997-09-09 BR BR9712816-3A patent/BR9712816A/pt not_active IP Right Cessation
- 1997-09-09 NZ NZ334895A patent/NZ334895A/xx not_active IP Right Cessation
- 1997-09-09 JP JP51324398A patent/JP4150427B2/ja not_active Expired - Fee Related
- 1997-09-09 US US09/242,389 patent/US6197824B1/en not_active Expired - Lifetime
- 1997-09-09 TR TR1999/00501T patent/TR199900501T2/xx unknown
- 1997-09-09 EP EP02003690A patent/EP1203764B1/fr not_active Expired - Lifetime
- 1997-09-09 ES ES97942007T patent/ES2184131T3/es not_active Expired - Lifetime
- 1997-09-09 DK DK97942007T patent/DK0929516T3/da active
- 1997-09-09 TW TW086113036A patent/TW378200B/zh not_active IP Right Cessation
- 1997-09-09 PL PL33213697A patent/PL188012B1/pl not_active IP Right Cessation
- 1997-09-09 KR KR1019997001964A patent/KR20000036005A/ko not_active Application Discontinuation
- 1997-09-09 CN CN97197748A patent/CN1104412C/zh not_active Expired - Fee Related
- 1997-09-09 HU HU9904367A patent/HUP9904367A3/hu unknown
- 1997-09-09 PT PT97942007T patent/PT929516E/pt unknown
- 1997-09-09 AU AU43838/97A patent/AU727900B2/en not_active Ceased
- 1997-09-09 AT AT97942007T patent/ATE224363T1/de active
- 1997-09-09 WO PCT/EP1997/004921 patent/WO1998011062A1/fr active IP Right Grant
- 1997-09-09 DE DE59711625T patent/DE59711625D1/de not_active Expired - Lifetime
- 1997-09-09 AT AT02003690T patent/ATE266630T1/de not_active IP Right Cessation
- 1997-09-09 DE DE59708278T patent/DE59708278D1/de not_active Expired - Lifetime
- 1997-09-09 CZ CZ0082299A patent/CZ297252B6/cs not_active IP Right Cessation
- 1997-09-09 CA CA002262566A patent/CA2262566C/fr not_active Expired - Fee Related
- 1997-09-09 EA EA199900279A patent/EA003245B1/ru not_active IP Right Cessation
- 1997-09-09 SK SK296-99A patent/SK282432B6/sk not_active IP Right Cessation
- 1997-09-10 AR ARP970104148A patent/AR009741A1/es active IP Right Grant
-
1999
- 1999-03-01 BG BG103219A patent/BG63938B1/bg active Active
- 1999-03-09 NO NO19991131A patent/NO312239B1/no not_active IP Right Cessation
- 1999-12-02 HK HK99105613A patent/HK1020564A1/xx not_active IP Right Cessation
-
2000
- 2000-12-01 US US09/728,856 patent/US6265612B1/en not_active Expired - Lifetime
-
2008
- 2008-04-16 JP JP2008107036A patent/JP4288299B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE04431B1 (et) | Bensamidiini derivaadid ja nende kasutamine LTB-4antagonistliku mõjuga ravimitena | |
| FI953479A0 (fi) | 1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö | |
| EE200200251A (et) | Uued N-asabitsükloamiidi derivaadid ja nende kasutamine | |
| EE9800459A (et) | Spiro-piperidiini derivaadid ja nende kasutamine terapeutiliste toimeainetena | |
| FI20002103A (fi) | Amidijohdannaisia ja nosiseptiiniantagonisteja | |
| DK0789562T3 (da) | Caffeinformulering med vedvarende afgivelse | |
| EE9900147A (et) | Oksadiasoolid, nende saamismeetodid ja kasutamine ravimitena | |
| ID22565A (id) | Penggunaan nanodispersi dalam formulasi akhir obat | |
| DK0984773T3 (da) | Farmaceutisk formulering med omeprazol | |
| ATE243516T1 (de) | Amoxicillin und clavulanat enthaltende arzneizubereitungen | |
| EE04151B1 (et) | Atsüülpiperasinüülpürimidiinide derivaadid, nendevalmistamine ja kasutamine ravimitena | |
| BR9707501A (pt) | Composto composição farmacêutica e uso do composto | |
| BR9602915A (pt) | Medicamentos uso e formulação farmacêutica | |
| PT1230230E (pt) | Derivados de indeno-di-hidrotiazole sua preparacao e sua utilizacao como medicamentos anorexigenico | |
| BR9707808A (pt) | Composto composição farmacêutica e uso do composto | |
| NO20001375L (no) | Legemiddelformulering med kontrollert virkestoffrigivning | |
| ZA989556B (en) | Benzoxazine derivatives their preparation and their therapeutic application | |
| FI954491A (fi) | Heterosykliä sisältäviä amidiinijohdokset, niiden valmistus ja käyttö | |
| BR9612413A (pt) | Composto uso do mesmo e composição farmacêutica | |
| NO20001717D0 (no) | Serotonin-inneholdende formulering for oral administrering og anvendelse av samme | |
| HUP0104238A2 (en) | Benzoxazole derivatives and drugs containing the same as the active ingredient and their use | |
| EE200000207A (et) | 8-asabitsüklo[3.2.1]oktaan-3-metaanamiini derivaadid, nende valmistamine ja terapeutiline kasutamine | |
| EE04095B1 (et) | Ketoliidide ja nende farmatseutiliselt vastuvõetavate soolade kasutamine farmatseutiliste kompositsioonide valmistamiseks | |
| IT1291823B1 (it) | Composti pseudo-peptidici, loro preparazione ed uso in formulazioni farmaceutiche | |
| EE200000018A (et) | 6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HC1A | Change of owner name | ||
| KB4A | Valid patent at the end of a year |
Effective date: 20051231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20061231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20071231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20081231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20101231 |
|
| MM4A | Lapsed by not paying the annual fees |
Effective date: 20120909 |